Sino Biopharmaceutical Limited (1177.HK)
HKD 3.97
(1.53%)
HKD 3.97
(1.53%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.12 Billion CNY | -41.28% |
| 2022 | 5.32 Billion CNY | 111.57% |
| 2021 | 2.51 Billion CNY | -29.78% |
| 2020 | 3.58 Billion CNY | 277.92% |
| 2019 | -2.01 Billion CNY | 28.6% |
| 2018 | -2.82 Billion CNY | -280.97% |
| 2017 | -740.84 Million CNY | -63.27% |
| 2016 | -453.74 Million CNY | 32.67% |
| 2015 | -673.94 Million CNY | 41.61% |
| 2014 | -1.15 Billion CNY | 47.55% |
| 2013 | -2.2 Billion CNY | -11.16% |
| 2012 | -1.97 Billion CNY | -20.79% |
| 2011 | -1.63 Billion CNY | 11.91% |
| 2010 | -1.86 Billion CNY | -15.72% |
| 2009 | -1.6 Billion CNY | -3.01% |
| 2008 | -1.56 Billion CNY | 2.98% |
| 2007 | -1.6 Billion CNY | 4.73% |
| 2006 | -1.68 Billion CNY | 4.35% |
| 2005 | -1.76 Billion CNY | -610.23% |
| 2004 | -248.57 Million CNY | -10.57% |
| 2003 | -224.81 Million CNY | 24.49% |
| 2002 | -297.7 Million CNY | -63.13% |
| 2001 | -182.49 Million CNY | -70.51% |
| 2000 | -107.02 Million CNY | -5880.66% |
| 1999 | -1.78 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 961.64 Million CNY | 17.2% |
| 2024 Q1 | 961.64 Million CNY | -69.26% |
| 2023 Q4 | 3.12 Billion CNY | -2.02% |
| 2023 FY | 3.12 Billion CNY | -41.28% |
| 2023 Q3 | 3.19 Billion CNY | 13908.2% |
| 2023 Q2 | -23.12 Million CNY | 62.04% |
| 2023 Q1 | -60.91 Million CNY | -101.14% |
| 2022 Q2 | 5.95 Billion CNY | 41.73% |
| 2022 Q4 | 5.32 Billion CNY | 167.5% |
| 2022 FY | 5.32 Billion CNY | 111.57% |
| 2022 Q3 | 1.99 Billion CNY | -66.54% |
| 2022 Q1 | 4.19 Billion CNY | 66.77% |
| 2021 FY | 2.51 Billion CNY | -29.78% |
| 2021 Q1 | 5.85 Billion CNY | 63.38% |
| 2021 Q2 | 5.62 Billion CNY | -3.98% |
| 2021 Q3 | 1.62 Billion CNY | -71.19% |
| 2021 Q4 | 2.51 Billion CNY | 55.4% |
| 2020 Q1 | -698.09 Million CNY | 65.36% |
| 2020 Q2 | -901.48 Million CNY | -29.13% |
| 2020 Q3 | 778.7 Million CNY | 186.38% |
| 2020 Q4 | 3.58 Billion CNY | 360.46% |
| 2020 FY | 3.58 Billion CNY | 277.92% |
| 2019 Q2 | -3.06 Billion CNY | -137.86% |
| 2019 Q1 | -1.28 Billion CNY | 54.4% |
| 2019 Q4 | -2.01 Billion CNY | -27.93% |
| 2019 FY | -2.01 Billion CNY | 28.6% |
| 2019 Q3 | -1.57 Billion CNY | 48.54% |
| 2018 FY | -2.82 Billion CNY | -280.97% |
| 2018 Q2 | -1.74 Billion CNY | -9.47% |
| 2018 Q1 | -1.59 Billion CNY | -115.16% |
| 2018 Q4 | -2.82 Billion CNY | -27.83% |
| 2018 Q3 | -2.2 Billion CNY | -26.53% |
| 2017 Q3 | -1.92 Billion CNY | -101.12% |
| 2017 Q4 | -740.84 Million CNY | 61.49% |
| 2017 Q2 | -956.61 Million CNY | -5.55% |
| 2017 Q1 | -906.32 Million CNY | -99.74% |
| 2017 FY | -740.84 Million CNY | -63.27% |
| 2016 FY | -453.74 Million CNY | 32.67% |
| 2016 Q3 | -1.17 Billion CNY | 28.7% |
| 2016 Q4 | -453.74 Million CNY | 61.37% |
| 2016 Q1 | -828.24 Million CNY | -22.9% |
| 2016 Q2 | -1.64 Billion CNY | -98.91% |
| 2015 FY | -673.94 Million CNY | 41.61% |
| 2015 Q4 | -673.94 Million CNY | 38.91% |
| 2015 Q2 | -913.93 Million CNY | 21.89% |
| 2015 Q1 | -1.17 Billion CNY | -1.37% |
| 2015 Q3 | -1.1 Billion CNY | -20.71% |
| 2014 Q4 | -1.15 Billion CNY | 45.46% |
| 2014 Q2 | -2.33 Billion CNY | 0.02% |
| 2014 Q3 | -2.11 Billion CNY | 9.55% |
| 2014 FY | -1.15 Billion CNY | 47.55% |
| 2014 Q1 | -2.34 Billion CNY | -6.35% |
| 2013 Q4 | -2.2 Billion CNY | 1.01% |
| 2013 FY | -2.2 Billion CNY | -11.16% |
| 2013 Q3 | -2.22 Billion CNY | -8.19% |
| 2013 Q2 | -2.05 Billion CNY | 6.93% |
| 2013 Q1 | -2.2 Billion CNY | -11.52% |
| 2012 Q3 | -2.14 Billion CNY | -14.66% |
| 2012 Q4 | -1.97 Billion CNY | 7.71% |
| 2012 FY | -1.97 Billion CNY | -20.79% |
| 2012 Q2 | -1.87 Billion CNY | 0.0% |
| 2011 Q4 | -1.63 Billion CNY | 6.86% |
| 2011 Q1 | -1.56 Billion CNY | 0.0% |
| 2011 FY | -1.63 Billion CNY | 11.91% |
| 2011 Q2 | -1.66 Billion CNY | -6.89% |
| 2011 Q3 | -1.75 Billion CNY | -5.47% |
| 2010 Q2 | -2.28 Billion CNY | 0.0% |
| 2010 FY | -1.86 Billion CNY | -15.72% |
| 2009 Q4 | -1.6 Billion CNY | 0.0% |
| 2009 FY | -1.6 Billion CNY | -3.01% |
| 2008 FY | -1.56 Billion CNY | 2.98% |
| 2007 FY | -1.6 Billion CNY | 4.73% |
| 2006 FY | -1.68 Billion CNY | 4.35% |
| 2005 FY | -1.76 Billion CNY | -610.23% |
| 2004 FY | -248.57 Million CNY | -10.57% |
| 2003 FY | -224.81 Million CNY | 24.49% |
| 2002 FY | -297.7 Million CNY | -63.13% |
| 2001 FY | -182.49 Million CNY | -70.51% |
| 2000 FY | -107.02 Million CNY | -5880.66% |
| 1999 FY | -1.78 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Uni-Bio Science Group Limited | -76.36 Million HKD | 4196.382% |
| CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 40.602% |